Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase
Authors:
- Arthur L. BurnettABArthur L. Burnett
- Wayne J. G. HellstromWHWayne J. G. Hellstrom
- Hunter C. ChampionHCHunter C. Champion
- 1 March 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 292 (3) , H1340-H1351
Abstract
Since both increased nitric oxide (NO) synthase (NOS) abundance and diminished NO signaling have been reported in the aging penis, the role of NO in the adaptations of aging remains controversial. Here we tested the hypothesis that arginase, an enzyme that competes with NOS for the substrate l-arginine, contributes to erectile dysfunction with advanced age in the B6/129 mouse strain. Arginase protein abundance, mRNA expression, and enzyme activity were elevated in aged compared with young penile endothelial cells. In addition, endothelial NOS (NOS3) protein abundance was greater in aged versus young penile endothelial cells, whereas NOS activity and cGMP levels were reduced. Calcium-dependent l-arginine-to-l-citrulline conversion and cGMP formation increased significantly in aged mouse penes in the presence of the arginase inhibitor 2( S)-amino-6-boronohexanoic acid (ABH). However, there was no effect on l-arginine-to-l-citrulline conversion or cGMP accumulation in the endothelium from young mouse penes. To assess the functional role of arginase in the inhibition of NOS pathway responsiveness in the penis, we evaluated the effects of ABH and an adeno-associated virus encoding an antisense sequence to arginase I (AAVanti-arginase) on erectile function in vivo. ABH and AAVanti-arginase enhanced endothelium-dependent erectile responses in the aged mice without altering endothelium-independent responses. Paralleling our in vitro observations, ABH or AAVanti-arginase did not affect vascular responses in the young mice. Inhibition of the arginase pathway improves endothelial function in the aging penile circulation, suggesting that the arginase pathway may be exploited to improve erectile dysfunction associated with aging.Keywords
This publication has 46 references indexed in Scilit:
- Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old RatsHypertension, 2006
- Modulation of In Vivo Cardiac Function by Myocyte-Specific Nitric Oxide Synthase-3Circulation Research, 2004
- Erectile Physiological and Pathophysiological Pathways Involved in Erectile DysfunctionJournal of Urology, 2003
- Gene Transfer of Endothelial Nitric Oxide Synthase Partially Restores Nitric Oxide Synthesis and Erectile Function in Streptozotocin Diabetic RatsJournal of Urology, 2003
- Increased Expression of Arginase II in Human Diabetic Corpus Cavernosum: In Diabetic-Associated Erectile DysfunctionBiochemical and Biophysical Research Communications, 2001
- Regulation of Nitric Oxide Production by Arginine Metabolic EnzymesBiochemical and Biophysical Research Communications, 2000
- Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the ratInternational Journal Of Impotence Research, 2000
- Effects of Long-term Oral Administration of L-Arginine on the Rat Erectile ResponseJournal of Urology, 1997
- Age Decreases Nitric Oxide Synthase-Containing Nerve Fibers in the Rat PenisJournal of Urology, 1997
- Nitric Oxide: A Physiologic Mediator of Penile ErectionScience, 1992